In the present study, 93.85% cases of
hyaline membrane disease have not received antenatal steroids whereas in the study by Dani et al [12] only 25.07% cases of
hyaline membrane disease have not received antenatal steroids.
Antenatal prediction of graduated risk of
hyaline membrane disease by amniotic fluid foam test for surfactant.
Hyaline membrane disease is confirmed by listening to the infant's lungs with a stethoscope, by analyzing blood gases and by examining x-ray images of the chest.
Surfactant therapy for
hyaline membrane disease: the Chandigarh experience.
Majority of cases are due to TTN followed by
hyaline membrane disease and meconium aspiration syndrome.
Progression from 'ground glass' density to 'white out' is a feature of
hyaline membrane diseaseIn this study commonest causes of apnoea was infection (51.02%) and apnoea of prematurity (29.59%), rest of the apnoeic episodes were caused by other diseases like birth asphyxia,
hyaline membrane diseases, intraventricular haemorrhage, hypoglycaemia, seizures and hypocalcaemia, which were responsible for 5.10%, 2.04%, 3.06%, 5.10%, 2.04% and 2.40% respectively which are very similar to the study done by Narang A et al 22% of infants with bacterial sepsis presented with apnoea in a study on clinical signs of bacterial sepsis in 455 newborn infants studied at four medical centers.
Respiratory Distress Syndrome (RDS) or
Hyaline Membrane Disease (HMD) is one of the most common causes of neonatal respiratory failure.
Hyaline membrane disease and Apnea as significant risk factor for ROP.
Respiratory distress syndrome,
hyaline membrane disease, hyposurfactosis are the most common conditions in preterm infants, appearing in approximately 60% of infants born before 30 weeks gestation.
Respiratory distress syndrome (RDS), or
hyaline membrane disease (HMD), has been recognized as the most common complication of prematurity, with more than half of those with a birth weight of between 501grams and 1500 grams showing signs of RDS.